CDSCO UID IMP/IVD/2023/000474_f493d4ae580def98991cc04ce44b39c4_bf295412cedd00558e3d1b87709cbd2f

ECL-100 Fully Automated Chemiluminescence Analyzer

Immunoconcept India Private Limited·Device Class Class A·India CDSCO·Brand: Epitope
Registration details
UID
IMP/IVD/2023/000474_f493d4ae580def98991cc04ce44b39c4_bf295412cedd00558e3d1b87709cbd2f
Device class
Class A
Brand name
Epitope
Approving authority
CDSCO
Product information
ECL100 is Fully Automated Chemiluminescence Analyzer and Europian The product is based on an acridine ester direct chemiluminescence method to perform qualitative or quantitative detection of analytes in human serum, plasma, whole blood, or fecal samples. For in vitro diagnostic use only."
Similar products (1)
Other products with the same name or brand
ECL25 Fully Automated Chemiluminescence Analyzer
Brand: Epitope
Immunoconcept India Private Limited
Class A
Other products from Immunoconcept India Private Limited
Products from the same license holder (10 products)
ECL25 Fully Automated Chemiluminescence Analyzer
Brand: Epitope
Class A
Insulin ELISA
Class B
17OH Progesterone ELISA
Class B
Free Testosterone ELISA
Class B
Aldosterone ELISA
Class B
Anti Tissue Translutaminase IgA
Class B
Saliva Collector Device
Class A
Estradiol ELISA
Class B
Thyroglobulin ELISA
Class B
Ferritin ELISA
Class B
About this record

ECL-100 Fully Automated Chemiluminescence Analyzer is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000474_f493d4ae580def98991cc04ce44b39c4_bf295412cedd00558e3d1b87709cbd2f. This device is marketed under the brand name Epitope. The license holder is Immunoconcept India Private Limited, and it is classified as Device Class Class A. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.